Background: Glucose-6 Phosphate Dehydrogenase (G6PD) Deficiency is one of the commonest inherited enzyme abnormalities in humans, caused by many mutations that reduce the stability of the enzyme and its level as red cells progress in age. Objectives: To determine the useful hematologic indicators of hemolysis, observe an early detection of G6PD enzyme deficiency (if any), and the available therapeutic measures. Patients and Methods: 123 patients with G6PD deficiency and hemolysis after exposure to fava beans whom visited AL-Elwiya Pediatric Teaching Hospital from the 1 st of February 2016 till 31 st of May 2016 were entered this study retrospectively. Hemolysis laboratory indicators were observed. Management supportive measures were put in consideration also. Results: We found that 10-20% levels of hematocrit and normochromic normocytic anemia were the most frequent on presentation, while a range of 15.1-20% of reticulocyte counts was the most common with lower rates in females group. Hyperbilirubinemia was seen with nil patients had abnormal renal function tests. About three quarters (76.4%) of the total number of involved cases had glucose-6-phosphate dehydrogenase (G6PD) deficiency. Only 4 patients required no blood transfusion, 102 patients (82.9%) needed transfusion once, and the rest 17 (13.8%) had more than one blood transfusion. Most of cases (91.1%) recovered within the first 3 days. However; all cases were recovered by the fourth day of admission. Conclusion: Hemoglobin and blood morphology with hyperbilirubinemia were useful hematologic indicators of hemolytic process, while blood transfusion was the most used therapeutic measure, and recovery was expected within 2-3 days.
Introduction:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common genetic abnormality known to predispose to acute hemolytic anemia (AHA), which can be triggered by certain drugs or infection. However, the commonest trigger is fava beans (Vicia faba) ingestion, causing AHA (favism), which may be lifethreatening especially in children. (1) A clinical symptom of G6PD deficiency closely linked to drug induced haemolysis is the hemolytic anemia resulting from the ingestion of the fava bean. (2,3) Patients with favism are always G6PD deficient, but not all G6PD deficient in-dividuals develop haemolysis when they ingest fava beans. It is assumed that some other factors, such as genetic and metabolism of the active ingredients in the beans, which causes oxidative damage in red blood cells, are involved. ingesting fava beans, more commonly in children, was reported. (4) In Mediterranean area, the major type of allele that exists is called the "Mediterranean" variant, among the population, whereas in other countries such as Japan there is a different variant with a different type of mutation prevalent within that population. This type of mutation is called the "Japan" variant. The Mediterranean variant, found in Southern Europe, the Middle East and in India, is characterized by very low enzyme activity (0-10%) in RBCs using spectrophotometric and potentiometric methods. (5) Deficiency of glucose-6-phosphate dehydrogenase (G6PD), an X-linked recessive enzymatic defect in the hexose monophosphate shunt that protects cellular damage from oxidative stress, is a common haematological problem worldwide. (6) At a public health level, preventive measures may be useful. Subjects with G6PD deficiency may not even know which fava beans are until they collapse with favism. Clinical signs and symptoms of hemolysis typically arise within 24 to 72 hours of drug dosing, and anemia worsens until about day (7). This makes it difficult for the health practitioner to identify a hemolytic crisis in patients who undergo outpatient or short hospital stay (less than 24 hour) procedures. Therefore, the practitioner should inform the high-risk patient and his or her caretaker to look for signs and symptoms of a hemolytic crisis (headache, dyspnea, fatigue, lumbar/substernal pain, jaundice, scleral icterus, and dark urine). (4) Treatment consists of discontinuation of the offending agent and maintenance of urine output by infusion of crystalloid solutions and diuretics such as mannitol and/or furesomide, with blood transfusion when needed. (4,18) Also, treatment of hyperbilirubinemia in G6PD-deficient neonates, when indicated, is with phototherapy and exchange transfusions. Prophylactic oral phenobarbital does not decrease the need for phototherapy or exchange transfusions in G6PD-deficient neonates. (19, 20) Aim of the study: To determine the useful hematologic indicators of hemolysis, observe an early detection of G6PD enzyme deficiency (if any), and the available therapeutic measures.
Patients and Methods:
Cases with history of fava beans ingestion reaching the emergency room of AL-Elwiya Pediatric Teaching Hospital during the period from the 1 st of February 2016 till 31 st of May 2016 were targeted retrospectively in this study, and their total number was 238 patients. The important investigations tracked from medical records includes: complete blood count with blood film and Reticulocyte count, direct Coomb's test, renal function tests, serum bilirubin (total and fractionated), as well as general urine examination (with urobilinogen) and G6PD enzyme assay screening test. Supportive measures in the form of intravenous fluids with or without blood transfusion were recorded from hospital files. Only fully recovered patients whom discharged in a good condition were allowed to enter this study. Any file of any patient that did not contain any of the above information was excluded.
Because of that; only 123 patients were involved out of 238, 101 of them were males and 22 were females. All of them were between 1-13 years old at time of diagnosis. Z-test to measure P-value was used for statistical evaluations.
Results:

Investigations: A. Hematocrit level (PCV):
The most frequent range of hematocrit levels that our patients got on presentation at the hospital was 10-20%, while less than 10% levels became next in frequency, as shown in Figure 1 . Figure 1 The range of hematocrit levels (during their first presentation at emergency department) Doing simple calculations based on figure (1) and results, we have 86 male patients (69.9%) out of the total (123 patients) whom had hematocrit levels  20%, compared to 17 females (13.9%). Z-test between 2 proportions = 3.54 P-value = 0.022. B. Type of anemia: Most of patients had normochromic normocytic anemia (118 patients; 95.9%) and only 5 patients (4.1%) had hypochromic microcytic red blood cells (1 male and 4 females). Nevertheles; 100 males (81.3%) out of the total (123 patients) had mean cell volume (MCV) levels > 70 femtoliter (fl) compared to 18 females (14.6%), which was the cut-line for microcytic red blood cells, while a level of mean cell hemoglobin concentation (MCH) less than 27 picogram (pg) was considered as hypochromic red blood cells. C. Reticulocyte count &RPI (reticulocyte production index): We found generally that reticulocyte counts (%) of 15.1 -20% were most common, but females favoured lower counts inside their group, as illustrated in Table 1 with a similar trend in case of reticulocyte production index (RPI) (21) . A value of 2-3 (of RPI) was the most frequent in both sex groups with a high percentage of 65% of total no. of patients (49.6% males and 15.5% females). Table 2 . F. Blood urea nitrogen and serum creatinine: Renal function (blood urea nitrogen and serum creatinine) was normal in all patients (100%), and so the function was not significantly impaired. G. G6PD enzyme assay: The deficiency was screened through de-coloration of methylene blue. Around 94 patients (76.4%) out of the total cases had deficient G6PD enzyme; most of them were males (90 patients) that stands for (73.4%) compared to 4 female patients, which represents (3.3%). This is obvious in Figure 4 . Z-test between 2 proportions = 2.56 P-value = 0.02.
Figure 4 G6PD enzyme
Treatment: Nearly all patients required blood transfusion, only 4 of them were considered with no need to blood as per the opinion of treating physician, also some patients required more than one time of blood transfusions as shown in Table 3 . This might be due to continuous hemolysis even with high initial hemoglobin levels. Recovery: It was dependent on regaining normal hematocrit levels (around 30%) for at least 12-24 hours.
As it is stated in table 4 below, all of the cases (100%) recovered from the disease within the 1 st 4 days, and (91.1%) recovered within the 1 st 3 days. 
Discussion:
Hematocrit level was  20% in majority of cases ; this level may be nearly similar to the results of a study from Mosul (22) , but lower than that mentioned by Segel GB. (23) . This may give us a clue of a more lower hematocrit levels in Iraqi patients rather than western populations. In 118 cases (95.9%), the anemia was of normochromic normocytic type, while the rest (5 cases) had hypochromic microcytic anemia. Nearly similar results were reported by Sawsan S. Abbas (24) , NelsonDA (25) , and ErbagclAB. (26) Reticulocyte count generally was high, precisely the RPI (Reticulocyte Production Index), which was between 2-3 in most of the involved cases; this indicates that hemolysis exceeded the ability of bone marrow to compensate, so the true reticulocyte count may be low for the first 3-4 days and this consistent with Hassan MK (27) and ErbagclAB. (26) 
